BBC vs. NFLX

In the year-to-date period, BBC achieves a 0.49% return, which is significantly lower than NFLX's 86.71% return. Over the past 10 years, BBC has underperformed NFLX with an annualized return of -0.51%, while NFLX has yielded a comparatively higher 34.26% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Netflix, Inc. (NFLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BBC Sharpe Ratio is 0.30, which is lower than the NFLX Sharpe Ratio of 2.90. The chart below compares the historical Sharpe Ratios of BBC and NFLX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

BBC's dividend yield for the trailing twelve months is around 0.99%, while NFLX has not paid dividends to shareholders.

The maximum BBC drawdown since its inception was -72.73%, smaller than the maximum NFLX drawdown of -81.99%. Use the drawdown chart below to compare losses from any high point for BBC and NFLX. For additional features, visit the drawdowns tool.

Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 11.33% compared to Netflix, Inc. (NFLX) at 7.30%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than NFLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.